MiR-203 expression is genetically regulated and contributes to patients’ outcomes [57] and MiR-203 transfection in liver cancer cells targets the 3′-UTR of MAT2A and MAT2B genes and strongly inhibits their expression. The gene discussed is MAT2A; the disease is liver cancer.